Dana Tegzová

2.9k citations
22 papers · 2.1k indexed · 2 hit papers · h-index 15
Topics
Systemic Lupus Erythematosus Research (13 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Rheumatoid Arthritis Research and Therapies (5 papers)

In The Last Decade

Dana Tegzová

21 papers receiving 2.0k citations

Hit Papers

A phase III, randomized, placebo-controlled study of beli...2011202620162021201120132505007501000

Peers

Dana Tegzová
Comparison fields: 5 of 76
  • Rheumatology 1.7k
  • Immunology 1.0k
  • Radiology, Nuclear Medicine and Imaging 657
  • Hematology 341
  • Oncology 250
Replace Omid Zamani with:
Omid Zamani United States
Agneta Zickert Sweden
C Tănăsescu Romania
Raymond F. Lum United States
William Shergy United States
Michelle Petri United States
Raymond E. Felgar United States
Paz Lavilla Spain
Michael A. Maldonado United States
M L Westedt Netherlands
Dana Tegzová relative to Omid Zamani United States Omid Zamani's profile →
Citations per field
00.5×1.5×
Omid Zamani · 1×
Citations per year

Countries citing papers authored by Dana Tegzová

Since Specialization
Citations

This map shows the geographic impact of Dana Tegzová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Tegzová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Tegzová more than expected).

Fields of papers citing papers by Dana Tegzová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Tegzová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Tegzová. The network helps show where Dana Tegzová may publish in the future.

Co-authorship network of co-authors of Dana Tegzová

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Tegzová. A scholar is included among the top collaborators of Dana Tegzová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Tegzová. Dana Tegzová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 25
4
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
14
5 2
6
Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.
16
7
Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic studybreakdown →
456
8 1
9
Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study
4
10 66
11 0
12
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusbreakdown →
1143
13 30
14 17
15 29
16 87
17
Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus.
7
18
Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment.
14
19 21
20 50

About Dana Tegzová

Dana Tegzová is a scholar working on Rheumatology, Nephrology and Hematology, having authored 22 papers that have together received 2.1k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (13 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). The work is most often cited by research in Rheumatology (1.7k citations), Immunology (1.0k citations) and Hematology (341 citations). Dana Tegzová has collaborated with scholars based in Czechia, United States and Brazil. Frequent co-authors include Douglas R. Hough, Z. John Zhong, Daniel J. Wallace, William Stohl, Winn Chatham, William W. Freimuth, Joan T. Merrill, Richard Furie, Ellen M. Ginzler and Jorge Sánchez‐Guerrero. Their work appears in journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Arthritis & Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026